DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,979,000 | -7.2% | 205,381 | 0.0% | 1.30% | +4.4% |
| Q2 2021 | $7,519,000 | -24.5% | 205,381 | -7.5% | 1.25% | -14.6% |
| Q1 2021 | $9,954,000 | -21.4% | 222,000 | 0.0% | 1.46% | -11.7% |
| Q4 2020 | $12,670,000 | +11.2% | 222,000 | 0.0% | 1.66% | -25.7% |
| Q3 2020 | $11,389,000 | -12.9% | 222,000 | 0.0% | 2.23% | -15.7% |
| Q2 2020 | $13,081,000 | +43.1% | 222,000 | 0.0% | 2.64% | +9.1% |
| Q1 2020 | $9,140,000 | -34.6% | 222,000 | -1.1% | 2.42% | -11.7% |
| Q4 2019 | $13,973,000 | +79.0% | 224,500 | -2.4% | 2.74% | -2.9% |
| Q3 2019 | $7,806,000 | +11.7% | 230,000 | -25.8% | 2.82% | +32.5% |
| Q2 2019 | $6,991,000 | -11.4% | 310,000 | -8.8% | 2.13% | -2.5% |
| Q1 2019 | $7,891,000 | +10.6% | 340,000 | 0.0% | 2.18% | -17.9% |
| Q4 2018 | $7,136,000 | -56.1% | 340,000 | -19.0% | 2.66% | -35.6% |
| Q3 2018 | $16,262,000 | -1.6% | 420,000 | 0.0% | 4.14% | -3.3% |
| Q2 2018 | $16,527,000 | +126.0% | 420,000 | +15.1% | 4.28% | +104.6% |
| Q1 2018 | $7,314,000 | +77.5% | 365,000 | +68.2% | 2.09% | +43.5% |
| Q3 2017 | $4,120,000 | – | 217,000 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |